MARC uses medications, such as methadone and buprenorphine, along with therapy, peer support, and other support services to help people recover from opioid use disorder (OUD). This is called medication assisted treatment (MAT), and it is considered the gold standard in treating opioid use disorder.
Methadone has been used to treat opioid use disorder for over 50 years. When used in MAT programs, it helps people sustain long-term success and reclaim active meaningful lives.
Methadone is a long-acting full opioid agonist that reduces opioid craving and withdrawal. It blunts, or blocks, the effects of opioids. We use it as part of a comprehensive treatment plan.
Methadone is safe and effective. We specifically tailor your dose to meet your health needs.
Buprenorphine is another medication used in MAT to treat OUD. It was approved for medical use by the Food and Drug Administration in 2002 and is largely used in the induction phase of treatment.
MARC uses buprenorphine as part of a comprehensive treatment plan to treat opioid dependency. Along with counseling and participation in social support systems, buprenorphine can diminish the withdrawal symptoms and cravings caused by opioid dependence.